checkAd

     550  0 Kommentare Actelion to discuss half year 2014 financial results

    Actelion Pharmaceuticals Ltd / Actelion to discuss half year 2014 financial results . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

    Dear member of the investment community

    Actelion Ltd will announce the half year 2014 financial results on Tuesday, 22 July 2014, at 07.00 hrs CEST / 06.00 hrs BST / 01.00 a.m. EDT. An investor conference call & webcast will be held at 14.00 hrs, CEST to discuss the results.

    Date/Time:

    22 July 2014 14.00 hrs Basel (CEST)
      13.00 hrs UK (BST)
      08.00 a.m US (EDT)

    Conference Call Connect #:

    Dial-in participants should start calling the number below 10-15 minutes before the conference is due to start.

    Dial: Europe: +41 (0) 22 580 29 91
      UK: +44 (0) 207 108 6206
      US: +1 866 305 6290

     

    Participant's mode:

    Listen-Only with possibility to open individual lines during Q&A session.
    Participants will be asked for their Name and Company.

    Webcast Access:

    Webcast participants should visit the Actelion website http://www.actelion.com
    10-15 minutes before the conference is due to start. 

    Participant's mode:

    Listen-Only          

    Webcast Replay:

    The archived Investor Webcast will be available for replay through http://www.actelion.com approximately 60 minutes after the call has ended.  





    This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    Source: Actelion Pharmaceuticals Ltd via Globenewswire

    HUG#1825415

    --- End of Message ---

    Actelion Pharmaceuticals Ltd
    Gewerbestrasse 16 Allschwil Switzerland

    ISIN: CH0010532478;





    GlobeNewswire
    0 Follower
    Autor folgen

    Verfasst von GlobeNewswire
    Actelion to discuss half year 2014 financial results Actelion Pharmaceuticals Ltd / Actelion to discuss half year 2014 financial results . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. Dear member of the investment …